Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Characteristics, Outcome, and Prognostic Factors for Survival and Progression to Multiple Myeloma of Solitary Plasmacytomas: A 30-Year Experience of the Greek Myeloma Study Group

Blood (2024) 144 (Supplement 1): 4673.

https://doi.org/10.1182/blood-2024-203776

Published: 2024

Journal Articles

Isatuximab in Combination with Pomalidomide and Dexamethasone in RRMM Patients with One Prior Line of Lenalidomide-Containing Therapy: A Phase 2 Study of the Greek Myeloma Study Group

Blood (2024) 144 (Supplement 1): 1991.

https://doi.org/10.1182/blood-2024-203519

Published: 2024

Journal Articles

Real-World Outcomes of Patients with Relapsed/Refractory Multiple Myeloma Treated with Teclistamab and Talquetamab; A Multicenter Analysis from the Greek Myeloma Study Group

Ioannis Ntanasis-Stathopoulos, Eirini Katodrytou, Evdoxia Hatjiharissi, Emmanouil Spanoudakis, Vasiliki Douka, Despina Fotiou, Vasiliki Labropoulou, Dimitra Dalampira, Vasiliki Spiliopoulou, Theodosia Papadopoulou, Dimitrios Christoulas, Panagiotis Malandrakis, Anthi Bouchla, Vasiliki Pappa, Efstathios Kastritis, Evangelos Terpos, Meletios Dimopoulos, Maria Gavriatopoulou

Blood (2024) 144 (Supplement 1): 6988.

https://doi.org/10.1182/blood-2024-206900

Published: 2024

Journal Articles

Bortezomib-Cyclophosphamide-Dexamethasone (VCD) Vs Bortezomib-Lenalidomide-Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma: A Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG)

Blood (2023) 142 (Supplement 1): 4734.

https://doi.org/10.1182/blood-2023-179416

Published: 2023

Journal Articles

Update Analysis of Central Nervous System Multiple Myeloma Prognosis and Survival: A Real-World Multi-Institutional Study of the Greek Myeloma Study Group

Blood (2023) 142 (Supplement 1): 1981.

https://doi.org/10.1182/blood-2023-181029

Published: 2023

Journal Articles

Improved Survival of Patients with Primary Plasma Cell Leukemia with VRD or Daratumumab-Based Quadruplets: A Multicenter Study By the Greek Myeloma Study Group

Blood (2022) 140 (Supplement 1): 4386–4387.

https://doi.org/10.1182/blood-2022-163065

Published: 2022

Journal Articles

Pomalidomide Plus Low Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: Results of the Real-World 'Powerful' Study

Blood (2020) 136 (Supplement 1): 33–35.

https://doi.org/10.1182/blood-2020-138390

Published: 2020

Journal Articles

Longer Duration and Proper Titration of Low Molecular Weight Heparin (LMWH), Are Independent Factors for Successful Pregnancy Outcome. Retrospective Analysis from a Single Center

Maria Stamou, Jr., Stergios Intzes, Jr., Eleftheria Lamprianidou, Menelaos Konstantinos Papoutselis, Zoe Bezirgiannidou, Evangelia Nakou, Zafeirios Kartasis, MD, Georgios Vrachiolias, Ioanna Bazntiara, Ioannis Kotsianidis, PhD, Emmanouil Spanoudakis

Blood (2018) 132 (Supplement 1): 5065.

https://doi.org/10.1182/blood-2018-99-113980

Published: 2018

Journal Articles

The Therapeutic Response of Myelodsyplastic Syndromes to Azacytidine Is Independent of Endogenous Retroelement Modulation

Chrysoula Kordella, Anastasiya Kazachenka, Eleftheria Lamprianidou, Emmanouela Zoulia, George Vrachiolias, Menelaos Konstantinos Papoutselis, Zoe Bezirgiannidou, Emmanouil Spanoudakis, Christiana Georgiou, Urszula Eksmond, George Kassiotis, Ioannis Kotsianidis, PhD

Blood (2018) 132 (Supplement 1): 4349.

https://doi.org/10.1182/blood-2018-99-114446

Published: 2018

Journal Articles

The STAT Signaling Biosignature at the Single Cell Level Reveals Novel Insights in the Association of FOXP3+ T Regulatory Cells with Recurrent Spontaneous Abortions (RSA)

Eleftheria Lamprianidou, Chryssoula Kordella, Antony Gerofotis, George Pantos, Emmanouil Spanoudakis, Athina Vasilaki, Michail Daniilidis, Ioannis Kotsianidis, MDPhD

Blood (2017) 130 (Supplement 1): 2285.

https://doi.org/10.1182/blood.V130.Suppl_1.2285.2285

Published: 2017

Journal Articles

Endogenous Retrovirus Derepression Drives Ectopic UGT2B17 Overexpression in Multiple Myeloma Cells: Molecular Sequelae and Pathophysiological Implications

Spyros Ioannis Papamichos, MD PhD, Eleftheria Lamprianidou, Chryssoula Kordella, Emmanouil Spanoudakis, Menelaos Konstantinos Papoutselis, Ioannis Kotsianidis, PhD

Blood (2017) 130 (Supplement 1): 4978.

https://doi.org/10.1182/blood.V130.Suppl_1.4978.4978

Published: 2017

Journal Articles

Expression Of CD25 Antigen On CD34+ Cells Is An Independent Predictor Of Survival In Late Stage MDS Patients Treated With Azacitidine

Ioannis Kotsianidis, Paraskevi Miltiades, Eleftheria Lamprianidou, Theodoros Vassilakopoulos, Sotirios G Papageorgiou, Athanasios G. Galanopoulos, Sofia Vakalopoulou, MD, PhD, Vassilia Garypidou, Emmanouil Spanoudakis, Maria Papaioannou, Evdoxia Hadjiharissi, Helen A Papadaki, Costas Tsatalas

Blood (2013) 122 (21): 1508.

https://doi.org/10.1182/blood.V122.21.1508.1508

Published: 2013

Journal Articles

Distinct Profile and Epigenetic Modulation Of STAT Signaling In FOXP3+ T Regulatory Cells Among The Various MDS Subtypes

Eleftheria Lamprianidou, Costas Tsatalas, Paraskevi Miltiades, Theodoros Vassilakopoulos, Athanasios G. Galanopoulos, Sotirios G Papageorgiou, Vassilia Garypidou, Sofia Vakalopoulou, MD, Emmanouil Spanoudakis, Dimitrios Margaritis, Ioannis Kotsianidis

Blood (2013) 122 (21): 1509.

https://doi.org/10.1182/blood.V122.21.1509.1509

Published: 2013

Journal Articles

Greek Registry Of Essential Thrombocythemia: Baseline Characteristics and Therapeutic Strategy

Blood (2013) 122 (21): 4084.

https://doi.org/10.1182/blood.V122.21.4084.4084

Published: 2013

Journal Articles

Over-Expression of RANKL In Invariant NKT Cells Is Characteristic of Active Myeloma but Not of MGUS or Asymptomatic Myeloma

Emmanouil Spanoudakis, Menelaos Papoutselis, Ioannis Kotsianidis, Evangelos Terpos, Meletios A. Dimopoulos, Ming Hu, PhD, Amin Rahemtulla, MBBS, PhD, FRCP, Dimitrios Margaritis, Georgios Bourikas, Konstantinos Tsatalas, Anastasios Karadimitris

Blood (2010) 116 (21): 4049.

https://doi.org/10.1182/blood.V116.21.4049.4049

Published: 2010

Journal Articles

Glucose Ceramide Synthase Inhibitors Inhibit Osteoclast Activation Induced by Myeloma-Derived and De Novo Synthesized Glycosphingolipids.

Ke Xu, MD, Aristotelis Antonopoulos, PhD, Emmanouil Spanoudakis, MD, PhD, Simon Parry, PhD, Aristeidis Chaidos, MD, PhD, Ming Hu, PhD, Terry Butters, PhD, Anne Dell, PhD, Amin Rahemtulla, MBBS, PhD, FRCP, Nikki Horwood, PhD, Anastasios Karadimitris, PhD, MRCP, FRCPath

Blood (2009) 114 (22): 424.

https://doi.org/10.1182/blood.V114.22.424.424

Published: 2009

Journal Articles

Correllation of Proteolytic Matrix Metalloproteases (MMPs) and Inhibitors (TIMPs) with JAK2V617F Mutation and Clinical Phenotype in BCR-ABL Negative Myeloproliferative Neoplasia (MPN).

C. M. Vadikolia, K. Anagnostopoulos, Despina Pantelidou, MD, PhD, G. Tripsianis, Emmanouil Spanoudakis, MD, PhD, Ioanna Bazdiara, Athanasios Anastasiadis, Dimitrios Margaritis, MD, PhD, A. Kortsaris, C. Tsatalas, Georgios Bourikas

Blood (2009) 114 (22): 1899.

https://doi.org/10.1182/blood.V114.22.1899.1899

Published: 2009

Journal Articles

Regulation of multiple myeloma survival and progression by CD1d

Emmanouil Spanoudakis, Ming Hu, Kikkeri Naresh, Evangelos Terpos, Valeria Melo, Alistair Reid, Ioannis Kotsianidis, Saad Abdalla, Amin Rahemtulla, Anastasios Karadimitris

Blood (2009) 113 (11): 2498–2507.

https://doi.org/10.1182/blood-2008-06-161281

Published: 2009

Journal Articles

Invariant NKT Cells Regulate Osteoclast Development and Function Under Homeostatic and during Conditions of Immune Activation

Ming Hu, J.H. Duncan Basssett, Lynette Danks, Emmanouil Spanoudakis, Ke Xu, Peter GT Howell, Alan Boyde, Nikki Horwood, Graham Williams, Irene AG Roberts, Anastasios Karadimitris

Blood (2008) 112 (11): 104.

https://doi.org/10.1182/blood.V112.11.104.104

Published: 2008

Journal Articles

Dynamics of Telomere Length and Telomerase Activity in Ph 1 -Negative Chronic Myeloproliferative Disorders

Ioanna Bazdiara, Despina Pantelidou, Athanasios Anastasiadis, Vassilios Papadopoulos, Dimitrios Margaritis, Emmanouil Spanoudakis, Georgios Xanthopoulidis, Ioannis Kotsianidis, Anna Christoforidou, Aggelos Goutzouvelidis, Georgios Bourikas, Konstantinos Tsatalas

Blood (2008) 112 (11): 2789.

https://doi.org/10.1182/blood.V112.11.2789.2789

Published: 2008

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Characteristics, Outcome, and Prognostic Factors for Survival and Progression to Multiple Myeloma of Solitary Plasmacytomas: A 30-Year Experience of the Greek Myeloma Study Group

Isatuximab in Combination with Pomalidomide and Dexamethasone in RRMM Patients with One Prior Line of Lenalidomide-Containing Therapy: A Phase 2 Study of the Greek Myeloma Study Group

Real-World Outcomes of Patients with Relapsed/Refractory Multiple Myeloma Treated with Teclistamab and Talquetamab; A Multicenter Analysis from the Greek Myeloma Study Group

Bortezomib-Cyclophosphamide-Dexamethasone (VCD) Vs Bortezomib-Lenalidomide-Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma: A Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG)

Update Analysis of Central Nervous System Multiple Myeloma Prognosis and Survival: A Real-World Multi-Institutional Study of the Greek Myeloma Study Group

Improved Survival of Patients with Primary Plasma Cell Leukemia with VRD or Daratumumab-Based Quadruplets: A Multicenter Study By the Greek Myeloma Study Group

Pomalidomide Plus Low Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: Results of the Real-World 'Powerful' Study

Longer Duration and Proper Titration of Low Molecular Weight Heparin (LMWH), Are Independent Factors for Successful Pregnancy Outcome. Retrospective Analysis from a Single Center

The Therapeutic Response of Myelodsyplastic Syndromes to Azacytidine Is Independent of Endogenous Retroelement Modulation

The STAT Signaling Biosignature at the Single Cell Level Reveals Novel Insights in the Association of FOXP3+ T Regulatory Cells with Recurrent Spontaneous Abortions (RSA)

Endogenous Retrovirus Derepression Drives Ectopic UGT2B17 Overexpression in Multiple Myeloma Cells: Molecular Sequelae and Pathophysiological Implications

Expression Of CD25 Antigen On CD34+ Cells Is An Independent Predictor Of Survival In Late Stage MDS Patients Treated With Azacitidine

Distinct Profile and Epigenetic Modulation Of STAT Signaling In FOXP3+ T Regulatory Cells Among The Various MDS Subtypes

Greek Registry Of Essential Thrombocythemia: Baseline Characteristics and Therapeutic Strategy

Over-Expression of RANKL In Invariant NKT Cells Is Characteristic of Active Myeloma but Not of MGUS or Asymptomatic Myeloma

Glucose Ceramide Synthase Inhibitors Inhibit Osteoclast Activation Induced by Myeloma-Derived and De Novo Synthesized Glycosphingolipids.

Correllation of Proteolytic Matrix Metalloproteases (MMPs) and Inhibitors (TIMPs) with JAK2V617F Mutation and Clinical Phenotype in BCR-ABL Negative Myeloproliferative Neoplasia (MPN).

Regulation of multiple myeloma survival and progression by CD1d

Invariant NKT Cells Regulate Osteoclast Development and Function Under Homeostatic and during Conditions of Immune Activation

Dynamics of Telomere Length and Telomerase Activity in Ph 1 -Negative Chronic Myeloproliferative Disorders

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only